Patricia Hurley, Joan Boren and Costantino Congiatu, PPD || June 2, 2015 More than $60 billion worth of patents on biological products are expiring before 2020, representing a major opportunity for the pharmaceutical industry.
Kristin Brooks, Associate Editor || October 14, 2014 While expensive and difficult to produce, Big Pharma is investing, looking to overcome the obstacles to development and commercialization that remain
Joseph Iacobucci and Damian Gant , Clinical Supplies and Xcelience || September 8, 2014 Getting packaged investigational materials dispensed to the patients taking part in clinical trials, on time and correctly, requires orchestrating myriad activities. Outsourcing makes the process even more complex. This series of articles presents tips on how to do it right.